Interaction Checker

Interacciones de Anastrozol

Anastrozol (Arimidex), inhibidor de la aromatasa, tiene 27 interacciones documentadas en las etiquetas de la FDA y las hojas informativas que indexamos. Graves: 17; moderadas: 0; leves: 0; casos en los que una etiqueta indica que no hay ninguna interacción significativa: 10. Cada entrada de abajo cita la frase que la respalda. Esta página del medicamento es un punto de partida, no un veredicto sobre su situación.

Qué aspecto tiene Anastrozol

Todas las versiones (9)
Anastrozol, tableta de 1 mg: blanca, redonda, 6 mm, con la inscripción Adx en una cara y 1 en la otra.
Adx / 1
1 mg · blanca · redonda · 6 mm
ANI
Anastrozol, tableta de 1 mg: blanca, redonda, 6 mm, con la inscripción A7.
A7
1 mg · blanca · redonda · 6 mm
BluePoint
Anastrozol, tableta de 1 mg: blanca, redonda, 6 mm, con la inscripción AN en una cara y 1 en la otra.
AN / 1
1 mg · blanca · redonda · 6 mm
Breckenridge
Anastrozol, tableta de 1 mg: blanca, redonda, 6 mm, con la inscripción YL en una cara y 111 en la otra.
YL / 111
1 mg · blanca · redonda · 6 mm
Yiling

Representaciones generadas a partir de los listados de productos de las etiquetas de la FDA: color, forma, tamaño e inscripción. 9 versiones documentadas de 15 etiquetadores.

Interacciones según la etiqueta

Interacciones graves (17)

  • Desogestrel y etinilestradiolanticonceptivo oralGrave

    Estrogen Estrogen-containing therapies should not be used with ARIMIDEX as they may diminish its pharmacological action. (etiqueta de Anastrozol, Interacciones medicamentosas)

  • Diacetato de etinodiol y etinilestradiolanticonceptivo oralGrave

    Estrogen Estrogen-containing therapies should not be used with ARIMIDEX as they may diminish its pharmacological action. (etiqueta de Anastrozol, Interacciones medicamentosas)

  • Drospirenona y etinilestradiolanticonceptivo oralGrave

    Estrogen Estrogen-containing therapies should not be used with ARIMIDEX as they may diminish its pharmacological action. (etiqueta de Anastrozol, Interacciones medicamentosas)

  • EstradiolestrógenoGrave

    Estrogen Estrogen-containing therapies should not be used with ARIMIDEX as they may diminish its pharmacological action. (etiqueta de Anastrozol, Interacciones medicamentosas)

  • Estradiol y dienogestanticonceptivo oralGrave

    Estrogen Estrogen-containing therapies should not be used with ARIMIDEX as they may diminish its pharmacological action. (etiqueta de Anastrozol, Interacciones medicamentosas)

  • Estradiol y noretisteronaestrógenoGrave

    Estrogen Estrogen-containing therapies should not be used with ARIMIDEX as they may diminish its pharmacological action. (etiqueta de Anastrozol, Interacciones medicamentosas)

  • Estrógenos conjugadosestrógenoGrave

    Estrogen Estrogen-containing therapies should not be used with ARIMIDEX as they may diminish its pharmacological action. (etiqueta de Anastrozol, Interacciones medicamentosas)

  • Estrógenos conjugados y bazedoxifenoestrógenoGrave

    Estrogen Estrogen-containing therapies should not be used with ARIMIDEX as they may diminish its pharmacological action. (etiqueta de Anastrozol, Interacciones medicamentosas)

  • Estrógenos esterificados y metiltestosteronaestrógenoGrave

    Estrogen Estrogen-containing therapies should not be used with ARIMIDEX as they may diminish its pharmacological action. (etiqueta de Anastrozol, Interacciones medicamentosas)

  • Etonogestrel y etinilestradiolestrógenoGrave

    Estrogen Estrogen-containing therapies should not be used with ARIMIDEX as they may diminish its pharmacological action. (etiqueta de Anastrozol, Interacciones medicamentosas)

  • FulvestrantestrógenoGrave

    Estrogen Estrogen-containing therapies should not be used with ARIMIDEX as they may diminish its pharmacological action. (etiqueta de Anastrozol, Interacciones medicamentosas)

  • Levonorgestrel y etinilestradiolanticonceptivo oralGrave

    Estrogen Estrogen-containing therapies should not be used with ARIMIDEX as they may diminish its pharmacological action. (etiqueta de Anastrozol, Interacciones medicamentosas)

  • Norelgestromina y etinilestradiolestrógenoGrave

    Estrogen Estrogen-containing therapies should not be used with ARIMIDEX as they may diminish its pharmacological action. (etiqueta de Anastrozol, Interacciones medicamentosas)

  • Noretisterona y etinilestradiolanticonceptivo oralGrave

    Estrogen Estrogen-containing therapies should not be used with ARIMIDEX as they may diminish its pharmacological action. (etiqueta de Anastrozol, Interacciones medicamentosas)

  • Norgestimato y etinilestradiolanticonceptivo oralGrave

    Estrogen Estrogen-containing therapies should not be used with ARIMIDEX as they may diminish its pharmacological action. (etiqueta de Anastrozol, Interacciones medicamentosas)

  • Norgestrel y etinilestradiolanticonceptivo oralGrave

    Estrogen Estrogen-containing therapies should not be used with ARIMIDEX as they may diminish its pharmacological action. (etiqueta de Anastrozol, Interacciones medicamentosas)

  • Tamoxifenomodulador selectivo de los receptores de estrógenosGrave

    • Tamoxifen: Do not use in combination with ARIMIDEX. (etiqueta de Anastrozol, Interacciones medicamentosas)

Sin interacción significativa según la etiqueta (10)

  • ApixabánanticoagulanteSin interacción

    Warfarin In a study conducted in 16 male volunteers, anastrozole did not alter the exposure (as measured by C max and AUC) and anticoagulant activity (as measured by prothrombin time, activated partial thromboplastin time, and thrombin time) of both R- and S-warfarin. (etiqueta de Anastrozol, Interacciones medicamentosas)

  • ArgatrobánanticoagulanteSin interacción

    Warfarin In a study conducted in 16 male volunteers, anastrozole did not alter the exposure (as measured by C max and AUC) and anticoagulant activity (as measured by prothrombin time, activated partial thromboplastin time, and thrombin time) of both R- and S-warfarin. (etiqueta de Anastrozol, Interacciones medicamentosas)

  • BivalirudinaanticoagulanteSin interacción

    Warfarin In a study conducted in 16 male volunteers, anastrozole did not alter the exposure (as measured by C max and AUC) and anticoagulant activity (as measured by prothrombin time, activated partial thromboplastin time, and thrombin time) of both R- and S-warfarin. (etiqueta de Anastrozol, Interacciones medicamentosas)

  • DabigatránanticoagulanteSin interacción

    Warfarin In a study conducted in 16 male volunteers, anastrozole did not alter the exposure (as measured by C max and AUC) and anticoagulant activity (as measured by prothrombin time, activated partial thromboplastin time, and thrombin time) of both R- and S-warfarin. (etiqueta de Anastrozol, Interacciones medicamentosas)

  • EdoxabánanticoagulanteSin interacción

    Warfarin In a study conducted in 16 male volunteers, anastrozole did not alter the exposure (as measured by C max and AUC) and anticoagulant activity (as measured by prothrombin time, activated partial thromboplastin time, and thrombin time) of both R- and S-warfarin. (etiqueta de Anastrozol, Interacciones medicamentosas)

  • EnoxaparinaanticoagulanteSin interacción

    Warfarin In a study conducted in 16 male volunteers, anastrozole did not alter the exposure (as measured by C max and AUC) and anticoagulant activity (as measured by prothrombin time, activated partial thromboplastin time, and thrombin time) of both R- and S-warfarin. (etiqueta de Anastrozol, Interacciones medicamentosas)

  • FondaparinuxanticoagulanteSin interacción

    Warfarin In a study conducted in 16 male volunteers, anastrozole did not alter the exposure (as measured by C max and AUC) and anticoagulant activity (as measured by prothrombin time, activated partial thromboplastin time, and thrombin time) of both R- and S-warfarin. (etiqueta de Anastrozol, Interacciones medicamentosas)

  • HeparinaanticoagulanteSin interacción

    Warfarin In a study conducted in 16 male volunteers, anastrozole did not alter the exposure (as measured by C max and AUC) and anticoagulant activity (as measured by prothrombin time, activated partial thromboplastin time, and thrombin time) of both R- and S-warfarin. (etiqueta de Anastrozol, Interacciones medicamentosas)

  • RivaroxabánanticoagulanteSin interacción

    Warfarin In a study conducted in 16 male volunteers, anastrozole did not alter the exposure (as measured by C max and AUC) and anticoagulant activity (as measured by prothrombin time, activated partial thromboplastin time, and thrombin time) of both R- and S-warfarin. (etiqueta de Anastrozol, Interacciones medicamentosas)

  • WarfarinaanticoagulanteSin interacción

    Warfarin In a study conducted in 16 male volunteers, anastrozole did not alter the exposure (as measured by C max and AUC) and anticoagulant activity (as measured by prothrombin time, activated partial thromboplastin time, and thrombin time) of both R- and S-warfarin. (etiqueta de Anastrozol, Interacciones medicamentosas)

Compruebe Anastrozol frente a todo lo que toma. Añada su lista completa; todos los pares se comprueban a la vez.

Abrir en el verificador

No es un consejo médico. La gravedad refleja la redacción de la etiqueta, no sus circunstancias. Una señal «grave» puede ser algo habitual bajo supervisión y una «leve» puede ser importante a dosis altas. Consulte a un farmacéutico.